A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers

Clinical trial NCT02728830 · COMPLETED

Trial details

NCT number: NCT02728830
Sponsor: AA Secord
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Gynecologic Neoplasms Epithelial Ovarian Cancer Uterine Endometrial Cancer Fallopian Tube Cancer Peritoneal Cancer

Start date: 2016-06-01
Primary completion: 2019-01-31
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.